Aurinia Pharmaceuticals Market Sentiment

Aurinia Pharmaceuticals Inc

AUPHNASDAQ

$16.60

0.030.18%

Last update: Aug 25, 10:20 AM

Market sentiment signals for Aurinia Pharmaceuticals (AUPH): analyst consensus, short interest, options flow and insider activity.

Analyst Consensus▲ Buy

Short Interest▲ 7.9% short float

Options Flow▲ 0.14 P/C ratio

Insider Activity— N/A

Analyst Consensus

Buy

6 analysts

Options Flow (P/C)

0.14

More calls — Bullish

77 calls · 11 puts

Avg Consensus PT

$16

-6.6%

Highest Price Target

$21

+26.5%

Jefferies

Lowest Price Target

$10

-39.8%

Cantor Fitzgerald

Short Interest

7.9%

Declining — Bullish

Insider Activity (30d)

—

Short Interest — % of Float

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Aug 7, 2026	RBC Capital	Douglas Miehm—	-3.6%	$15 → $16	Maintained	Sector Perform
Dec 3, 2025	Leerink Partners	Joseph Schwartz—	-3.6%	$15 → $16	Downgrade	Outperform→Market Perform
Nov 7, 2025	Jefferies	Maury Raycroft—	+26.5%	$10 → $21	Upgrade	Hold→Buy
Nov 5, 2025	RBC Capital	Douglas Miehm—	-9.6%	$9 → $15	Downgrade	Outperform→Sector Perform
Aug 1, 2025	RBC Capital	Douglas Miehm—	-45.8%	$8 → $9	Maintained	Outperform
Jul 30, 2025	HC Wainwright & Co.	Arthur He—	+2.4%	$17	Assumes	Buy
Sep 16, 2024	Cantor Fitzgerald	Olivia Brayer—	-39.8%	$10 → $10	Maintained	Overweight
Sep 9, 2024	Cantor Fitzgerald	Olivia Brayer—	-39.8%	$10 → $10	Maintained	Overweight
Sep 6, 2024	HC Wainwright & Co.	Ed Arce—	-21.7%	$13 → $13	Maintained	Buy
Mar 1, 2024	HC Wainwright & Co.	Ed Arce—	-21.7%	$13 → $13	Maintained	Buy
Feb 23, 2024	Cantor Fitzgerald	Olivia Brayer—	-39.8%	$12 → $10	Maintained	Overweight
Feb 22, 2024	HC Wainwright & Co.	Ed Arce—	-21.7%	$15 → $13	Maintained	Buy
Feb 16, 2024	RBC Capital	Douglas Miehm—	-51.8%	$13 → $8	Maintained	Outperform
Sep 22, 2023	HC Wainwright & Co.	Ed Arce—	-9.6%	$15	Maintained	Buy